anmelden
SLI
2.318,31
PKT
-8,99
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.07.23 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 07.07.23 | Swiss Re Equal Weight | Barclays Capital | |
| 07.07.23 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.07.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 06.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.07.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 05.07.23 | Roche Hold | Jefferies & Company Inc. | |
| 05.07.23 | Novartis Buy | Jefferies & Company Inc. | |
| 04.07.23 | Givaudan Add | Baader Bank | |
| 04.07.23 | Richemont Market-Perform | Bernstein Research | |
| 04.07.23 | Nestlé Market-Perform | Bernstein Research | |
| 04.07.23 | UBS Buy | Deutsche Bank AG | |
| 03.07.23 | Richemont Buy | UBS AG | |
| 03.07.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.07.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 03.07.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.06.23 | Richemont Neutral | Credit Suisse Group | |
| 30.06.23 | UBS Sector Perform | RBC Capital Markets | |
| 30.06.23 | Richemont Overweight | Barclays Capital | |
| 30.06.23 | Nestlé Underperform | RBC Capital Markets | |
| 29.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.06.23 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.06.23 | Nestlé Market-Perform | Bernstein Research | |
| 28.06.23 | Nestlé Market-Perform | Bernstein Research | |
| 28.06.23 | Richemont Outperform | RBC Capital Markets | |
| 28.06.23 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 27.06.23 | Nestlé Underperform | RBC Capital Markets | |
| 26.06.23 | Givaudan Sell | UBS AG | |
| 26.06.23 | UBS Underweight | Barclays Capital | |
| 23.06.23 | Givaudan Hold | Deutsche Bank AG | |
| 23.06.23 | Givaudan Sell | UBS AG | |
| 22.06.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 22.06.23 | Roche Sell | Deutsche Bank AG | |
| 22.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 22.06.23 | Richemont Overweight | JP Morgan Chase & Co. | |
| 20.06.23 | Roche Sell | Deutsche Bank AG | |
| 16.06.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 15.06.23 | Novartis Underweight | Barclays Capital | |
| 15.06.23 | Roche Neutral | UBS AG | |
| 15.06.23 | Novartis Neutral | UBS AG |
